Steinberg S, de Jong S, Mattheisen M, Costas J, Demontis D, Jamain S, Pietiläinen O P H, Lin K, Papiol S, Huttenlocher J, Sigurdsson E, Vassos E, Giegling I, Breuer R, Fraser G, Walker N, Melle I, Djurovic S, Agartz I, Tuulio-Henriksson A, Suvisaari J, Lönnqvist J, Paunio T, Olsen L, Hansen T, Ingason A, Pirinen M, Strengman E, Hougaard D M, Orntoft T, Didriksen M, Hollegaard M V, Nordentoft M, Abramova L, Kaleda V, Arrojo M, Sanjuán J, Arango C, Etain B, Bellivier F, Méary A, Schürhoff F, Szoke A, Ribolsi M, Magni V, Siracusano A, Sperling S, Rossner M, Christiansen C, Kiemeney L A, Franke B, van den Berg L H, Veldink J, Curran S, Bolton P, Poot M, Staal W, Rehnstrom K, Kilpinen H, Freitag C M, Meyer J, Magnusson P, Saemundsen E, Martsenkovsky I, Bikshaieva I, Martsenkovska I, Vashchenko O, Raleva M, Paketchieva K, Stefanovski B, Durmishi N, Pejovic Milovancevic M, Lecic Tosevski D, Silagadze T, Naneishvili N, Mikeladze N, Surguladze S, Vincent J B, Farmer A, Mitchell P B, Wright A, Schofield P R, Fullerton J M, Montgomery G W, Martin N G, Rubino I A, van Winkel R, Kenis G, De Hert M, Réthelyi J M, Bitter I, Terenius L, Jönsson E G, Bakker S, van Os J, Jablensky A, Leboyer M, Bramon E, Powell J, Murray R, Corvin A, Gill M, Morris D, O'Neill F A, Kendler K, Riley B, Craddock N, Owen M J, O'Donovan M C, Thorsteinsdottir U, Kong A, Ehrenreich H, Carracedo A, Golimbet V, Andreassen O A, Børglum A D, Mors O, Mortensen P B, Werge T, Ophoff R A, Nöthen M M, Rietschel M, Cichon S, Ruggeri M, Tosato S, Palotie A, St Clair D, Rujescu D, Collier D A, Stefansson H, Stefansson K
deCODE genetics, Reykjavik, Iceland.
Center for Neurobehavioral Genetics, UCLA, Los Angeles, CA, USA.
Mol Psychiatry. 2014 Jan;19(1):108-14. doi: 10.1038/mp.2012.157. Epub 2012 Nov 20.
Epidemiological and genetic data support the notion that schizophrenia and bipolar disorder share genetic risk factors. In our previous genome-wide association study, meta-analysis and follow-up (totaling as many as 18 206 cases and 42 536 controls), we identified four loci showing genome-wide significant association with schizophrenia. Here we consider a mixed schizophrenia and bipolar disorder (psychosis) phenotype (addition of 7469 bipolar disorder cases, 1535 schizophrenia cases, 333 other psychosis cases, 808 unaffected family members and 46 160 controls). Combined analysis reveals a novel variant at 16p11.2 showing genome-wide significant association (rs4583255[T]; odds ratio=1.08; P=6.6 × 10(-11)). The new variant is located within a 593-kb region that substantially increases risk of psychosis when duplicated. In line with the association of the duplication with reduced body mass index (BMI), rs4583255[T] is also associated with lower BMI (P=0.0039 in the public GIANT consortium data set; P=0.00047 in 22 651 additional Icelanders).
流行病学和遗传学数据支持精神分裂症和双相情感障碍具有共同遗传风险因素这一观点。在我们之前的全基因组关联研究、荟萃分析及后续研究(总计多达18206例病例和42536例对照)中,我们确定了4个与精神分裂症存在全基因组显著关联的基因座。在此,我们考虑一种精神分裂症和双相情感障碍(精神病)的混合表型(新增7469例双相情感障碍病例、1535例精神分裂症病例、333例其他精神病病例、808例未患病家庭成员以及46160例对照)。联合分析揭示了16p11.2处的一个新变异,其显示出全基因组显著关联(rs4583255[T];优势比 = 1.08;P = 6.6×10⁻¹¹)。这个新变异位于一个593 kb的区域内,该区域在发生重复时会大幅增加患精神病的风险。与该重复与降低体重指数(BMI)的关联一致,rs4583255[T]也与较低的BMI相关(在公共GIANT财团数据集中P = 0.0039;在另外22651名冰岛人中P = 0.00047)。